Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Early Stage Triple Negative ER Low Breast Cancer × Interleukin 1 Receptor Antagonist Protein × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 3 Mucositis 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, B-Cell 2 Febrile Neutropenia 2 Polycystic Ovary Syndrome 1 Neurotoxicity Syndromes 1 Neoplasms, Plasma Cell 1 Lymphoma, Non-Hodgkin 1 Inflammation 1 Hematologic Neoplasms 1 Early Stage Triple Negative ER Low Breast Cancer 1 Disease Progression 1 Cytokine Release Syndrome 1 Colorectal Neoplasms 1 Burkitt Lymphoma 1 Arthritis, Rheumatoid 1

Interventions

Interleukin 1 Receptor Antagonist Protein 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06710197 2026-03-05

OZM-034

University Health Network, Toronto

Phase 2 Withdrawn

Early Stage Triple Negative ER Low Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡